Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
Parvaneh Baghaei, Farzaneh Dastan, Majid Marjani, Afshin Moniri, Zahra Abtahian, Somayeh Ghadimi, Melika Valizadeh, Jalal Heshmatnia, Maryam Sadat Mirenayat, Atefeh Abedini, Arda Kiani, Alireza Eslaminejad, Seyed Mohammad Reza Hashemian, Hamidreza Jamaati, Alireza Zali, Ali Akbar Velayati, Payam Tabarsi
Topics & Concepts
LopinavirMedicineRitonavirLopinavir/ritonavirInternal medicineComorbidityRetrospective cohort studyGastroenterologyCoronavirus disease 2019 (COVID-19)ImmunologyViral loadVirusDiseaseAntiretroviral therapyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19